December 8, 2022
An FDA Gift to Dexcom
Now I don’t want to put a lump of coal in Dexcom’s Xmas stocking but this morning’s announcement that the FDA had finally approved the G7 was like finding out that Georgia was going to be the number one seed in the college football playoffs. Everyone knew the G7 would eventually gain approval which is likely why the stock while up it isn’t skyrocketing. With G7 now approved everyone else can about pontificating about the battle Royale between the Libre3 and the G7 or Abbott vs. Dexcom Cage Match #3.
Here is a more realistic take . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.